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Abstract 
How easy is it to reproduce the results found in a typical computational biology paper? 
Either through experience or intuition the reader will already know that the answer is 
with difficulty or not at all. In this paper we attempt to quantify this difficulty by 
reproducing a previously published paper for different classes of users (ranging from 
users with little expertise to domain experts) and suggest ways in which the situation 
might be improved. Quantification is achieved by estimating the time required to 
reproduce each of the steps in the method described in the original paper and make them 
part of an explicit workflow that reproduces the original results. Reproducing the 
method took several months of effort, and required using new versions and new 
software that posed challenges to reconstructing and validating the results. The 
quantification leads to “reproducibility maps” that reveal that novice researchers would 
only be able to reproduce a few of the steps in the method, and that only expert 
researchers with advance knowledge of the domain would be able to reproduce the 
method in its entirety. The workflow itself is published as an online resource together 
with supporting software and data. The paper concludes with a brief discussion of the 
complexities of requiring reproducibility in terms of cost versus benefit, and a 
desiderata with our observations and guidelines for improving reproducibility. This has 
implications not only in reproducing the work of others from published papers, but 
reproducing work from one’s own laboratory. 
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Introduction 
Computation is now an integral part of the biological sciences either applied as a 
technique or as a science in its own right - bioinformatics. As a technique, software 
becomes an instrument to analyze data and uncover new biological insights. By reading 
the published article describing these insights, another researcher hopes to understand 
what computations were carried out, replicate the software apparatus originally used and 
reproduce the experiment. This is rarely the case without significant effort, and 
sometimes impossible without asking the original authors. In short, reproducibility in 
computational biology is aspired to, but rarely achieved. This is unfortunate since the 
quantitative nature of the science makes reproducibility more obtainable than in cases 
where experiments are qualitative and hard to describe explicitly. 
An intriguing possibility where potential quantification exists is to extend articles 
through the inclusion of scientific workflows that represent computations carried out to 
obtain the published results, thereby capturing data analysis methods explicitly [1]. This 
would make scientific results more reproducible because articles would have not only a 
textual description of the computational process described in the article but also a 
workflow that, as a computational artifact, could be analyzed and re-run automatically. 
Consequently, workflows can make scientists more productive because they capture 
complex methods in an easy to use accessible manner [2]–[3]. 
The goal of this article is, by applying a workflow to an existing computational analysis 
[4], to describe and quantify the effort involved in reproducing the published 
computational method and to articulate guidelines for authors that would facilitate 
reproducibility and reuse. Quantification is achieved by assigning a reproducibility 
score that exposes the cost of omitting important information from the published paper 
that then caused problems in creating the workflow. Beyond this no case is made for the 
value of workflows which is well described elsewhere [3]. 
Related Work 
As stated, scientific articles describe computational methods informally, as the 
computational aspects of the method may not be the main focus of the article. We 
acknowledge that in computer science the method may be described formally and any 
limitations, it could be argued, reside with the editors and reviewers. However, in the 
domain of computational biology, which is the focus here, we believe methods to be, for 
the most part, described informally as formalizations are not typically favored by 
authors or enforced by reviewers. 
Computational methods are often complex and hard to explain in textual form with the 
given space limitations of many articles. As a result, reproducing methods often 
requires significant effort from others to reproduce and reuse. Studies have shown that 
reproducibility is not achievable from the article itself, even when datasets are published 
[5]–[7]. The reproducibility process can be so costly that it has been referred to as 
“forensic” research [8]. Lack of reproducibility also affects the review process and as a 
result retractions of publications occur more often than is desirable [9]. A recent 
editorial proposed tracking the “retraction index” of scientific journals to indicate the 
proportion of published articles that are later found problematic [10]. Publishers 
themselves are asking the community to end “black box” science that cannot be easily 
reproduced [11]. Pharmaceutical companies report abandoning efforts to reproduce 
research that seemed initially promising and worth investigating after substantial 
investments [12]. 
Computational reproducibility is a relatively modern concept. The Stanford Exploration 
Project led by Jon Claerbout published an electronic book containing a dissertation and 
other articles from their geosciences lab [13]. Papers are accompanied by zipped files 
with the software that could be used to reproduce the results, and a methodology was 
developed to create and manage all these objects that continue today with the 
Madagascar software [14]. Advocates of reproducibility have sprung up over the years 
in many disciplines, from signal processing [15] to psychology [16]. Organized 
community efforts include reproducibility tracks at conferences [17]–[19], 
reproducibility editors in journals [20], and numerous community workshops and 
forums (e.g., [21], [22]). Active research in this area is addressing a range of topics 
including copyright [23], privacy [24], social [25] and validation issues [26]. 
Scientific publications could be extended so that they incorporate computational 
workflows, as many already include data [1]. Without access to the source codes for the 
papers, reproducibility has been shown elusive [7]. This would make scientific results 
more easily reproducible because articles would have not just a textual description of 
the computational process used but also a workflow that, as a computational artifact, 
could be inspected and automatically re-executed. Some systems exist that augment 
publications with scripts or workflows, such as Weaver for Latex [27]–[28] and 
GenePattern for MS Word [29]. Many scientific workflow systems now include the 
ability to publish provenance records [30]–[31]. The Open Provenance Model was 
developed by the scientific workflow community and is extensively used for this 
purpose [32]. Here we make a contribution to the on-going discussion of reproducibility 
by attempting to quantify what reproducibility implies. 
Methods and Analysis 
Quantifying Reproducibility 
We focus on an article that describes a method that lends itself to workflow 
representation, since others can, in principle, use the same exact procedures [4]. The 
article describes a computational pipeline that, as applied, maps all putative FDA and 
European drugs to possible protein receptors within a given proteome; Mycobacterium 
tuberculosis (TB) in the paper under study. Mapping is limited to the accessible 
structural proteome of experimental structures and high quality homology models. 
Mapping is performed using a binding site comparison algorithm which compares the 
binding site of the drug bound to a primary protein receptor to potential binding sites 
found on every available protein in a given proteome. Docking of the drug to the off-
target protein is used to further validate the predicted binding. The study uses data from 
the RCSB Protein Data Bank (PDB [33]) and Modbase [34]. The resultant “drugome” 
established multiple receptors to which a given drug can bind and multiple drugs that 
could bind to a given receptor. As such it is a putative map of possible drug 
repositioning strategies in treating a given condition caused by a pathogen. Although the 
article focuses on Mycobacterium tuberculosis (TB), according to the article’s abstract: 
“… the methodology may be applied to other pathogens of interest with results 
improving as more of their structural proteomes are determined through the continued 
efforts of structural biology/genomics.” 
That is, the methodology is likely to be repeated for other organisms and/or repeated in 
the same organism as more drugs become available and/or more of the structural 
proteome becomes available. The original work did not use a workflow system; instead 
the computational steps were run separately and manually. The original work was done 
over a period of two years, with different authors having different degrees of 
participation in the design and the programming aspects of the study. There is a TB 
Drugome project site where many details about the work can be found [35]. 
The original article was used to challenge participants at the first Beyond the PDF 
workshop [21]. The workshop attracted participants interested in bettering the 
communication and comprehension of science. The challenge was to apply the tools 
they had developed to illustrate their value on a given piece of science to which, as far 
as possible, all lab notes, raw data, software, drafts of the paper etc. where made 
available. The work described here is one outcome of these efforts and is aimed at 
addressing the questions: What can we gain from the process of workflow creation and 
what does it tell us about reproducibility? 
The rest of this paper describes our attempt to answer these questions. Many details of 
the analysis and how progress was made in reproducing the method are available on the 
project site [36]. Also Supplement S1 includes a more detailed analysis and the thought 
processes that occurred. 
Methodology 
The workflow was reproduced as a joint effort between computer scientists and the 
original authors of the article. Although some of the authors of the paper had moved to 
other research groups (notably Kinnings, its first author), they were still available to 
answer questions and provide software scripts and data as needed. 
We present a detailed analysis of the issues that came up in reproducing three major 
parts of the methods section in the original paper. These three parts were originally fully 
automated. Other steps of the method, notably the initial steps to obtain the data and the 
final steps for visualization and presentation, were manually done and not considered as 
part of the workflow presented here. 
We describe how each of the three method subsections was implemented as a workflow. 
Each computational step corresponds to an execution of an existing tool or a script 
written by the paper authors. We were able to recreate the workflow in the Wings 
workflow system [37]–[39] to make sure it was executable and reproduced the original 
results reported in the paper. Hence, the workflow explicitly represents the method that 
the authors meant to convey in the original text, that is, the process by which software 
and data are used to achieve the published result. 
Based on this explicit computational workflow, we present an analysis of the 
reproducibility of each subsection. We considered reproducibility by researchers of four 
types: 
1. REP‐AUTHOR, is a researcher who did the original work and who may need to 
reproduce the method to update or extend the results published. It is assumed that 
the authors have enough backup materials to answer any questions that arise in 
reconstructing the method. In practice, some authors may be students that move 
away from the lab and their materials and notes may or may not be available, 
confounding reproducibility [40]. 
2. REP‐EXPERT is a researcher familiar with the research area. These researchers could 
reproduce the method even if the methods section of the paper is incomplete and 
ambiguous. They can use their knowledge of the domain, the software tools and the 
process to make very complex inferences from the text and reconstruct the method. 
However, there may be some non‐trivial inferences that require significant effort. 
3. REP‐NOVICE is a researcher with basic bioinformatics expertise. They may be asked to 
use the method with new data, but are only able to make limited inferences based on 
analyzing the text and software tools. For them reproducibility can be very costly since 
it may involve a lot of trial and error, or perhaps additional research. In some cases 
reproducibility may become impossible. 
4. REP‐MINIMAL is a researcher with no expertise in bioinformatics. They need some 
programming skills to assemble the software necessary to run the different steps of 
the method. They represent researchers from other areas of science with minimal 
knowledge about biology, students, and even entrepreneurial citizen scientists (e.g., 
[41]). Unless the steps of the method are explicitly stated, they would not be able to 
reproduce the results. 
In our work, we did not ask experts to reproduce the method, so we only have three 
categories of researcher rather than four. We used the following approach: 
 REP‐MINIMAL ‐ The computer scientists in the team read the article and formulated 
the initial workflows. They have minimal background knowledge in biology. 
 REP‐NOVICE ‐ The computer scientists subsequently consulted the documentation on 
the software tools mentioned in the article to try to infer how the data were being 
processed by each of the steps of the method. Based on this, they refined their initial 
workflows. 
 REP‐AUTHOR ‐ Lastly the computer scientists approached the original paper authors to 
ask specific questions, resolve execution failures and errors and consult concerning the 
validity of the results for each step. They created the final workflow based on these 
conversations with the authors. 
We analyzed each of the workflow steps in terms of: whether the existence of the step 
itself was clear to the reproducers, whether the software that was used to run the step 
was clear to the reproducers, and whether their inputs and outputs were clear. For 
example, the existence of a step to compare ligand binding sites is mentioned in the text 
of the original paper, and the fact that it was carried out using the SMAP software [42] 
is also explicit in the text, so those would be things that the REP-MINIMAL 
reproducers were able to figure out. The use of a p-value as an input was not mentioned 
in the text and cannot be easily inferred unless the researcher reproducing the method 
becomes familiar with the software, so REP-NOVICE reproducers were able to figure 
out this parameter. 
For this analysis, we assigned a reproducibility score to each aspect of the workflow for 
each of these reproducer categories. A score of 1 in a category means that, in our 
assessment, a prototypical researcher of that category would be able to figure out the 
item. A score of 0 means that they would not be likely to figure it out without help from 
experts. 
Based on these scores, we designed a reproducibility map, where the reproducibility of 
each computational step was highlighted to determine how far each category of 
researcher could go in reproducing a given workflow fragment. 
Finally, we report on the effort involved in creating the workflow, measured as the time 
spent on various aspects of the work involved in reproducing the method described in 
the original article. 
Conceptual Overview of the Method and Final Workflow 
An interesting result of our initial discussions of the method was a collaborative 
diagram that indicated each of the steps in the method and how data were generated and 
used by each step. This diagram, shown in Figure 1, makes the steps of the method 
more explicit and adds useful information to the text in the methods section. It also 
shows where the data in the tables of the article fit into the method. 
 
Figure 1. A high‐level dataflow diagram of the TB drugome method. 
doi:10.1371/journal.pone.0080278.g001 
In essence, the bulk of the results in the paper are obtained through three major steps: 
1. Comparison of ligand binding sites, which compares the putative binding sites of 
solved protein structures and homology models (obtained from queries to the PDB and 
other sources) against the binding sites from protein structures where approved drugs 
are bound. This step used the SMAP software [42]. 
2. Comparison of protein structures, optimizing their alignment as well as reporting on 
the statistical significance of the structural similarity. This step used the FATCAT 
software [43] and is in essence a filtering step to remove structures which have overall 
global similarity and hence likely to be in the same protein family, since we are 
interested in similar binding sites found in otherwise dissimilar proteins. 
3. Molecular docking, to predict the binding and affinity of the proteins and drug 
molecules. This step used the eHits software [44]. 
Based on our experience, authors should be encouraged to publish such high-level 
flow diagrams as a normal part of the materials and methods section of a paper. 
The diagrams provide a high level overview of the method, highlights major steps, and 
offer a roadmap for reproducibility. 
The final workflow with the four steps that reproduced the method is shown in Figure 2. 
We highlight the first three major subsections of the method. In order to validate the 
new results, we used the same inputs (drug binding sites, solved structures, and 
homology models) as in the original work. However, these inputs point to external data 
sources (like the PDB) where the data are stored. These third-party data sources had 
been updated, and therefore the workflow execution produced slightly different results 
than the results reported in the original article. A detailed comparison of the original 
results and the results of the new workflow is provided in Supplement S1. 
 
Figure 2. The reproduced TB Drugome workflow with the different subsections highlighted. 
(1) Comparison of ligand binding sites using SMAP; (2) protein structure comparison 
using FATCAT; (3) docking using Autodock Vina; and (4) graph network creation 
(visualization). We focus on the reproducibility of sections 1-3 here. 
doi:10.1371/journal.pone.0080278.g002 
Reproducibility Analysis 
We now analyze each of the subsections of the method as described in the original 
paper, discussing the difficulties encountered in reproducing the method, highlighting 
recommendations to improve reproducibility, and show reproducibility scores for each 
step of the final workflow. An extended analysis of each subsection of the method is 
available in Supplement S1, detailing the evolution of each sub-workflow in order to 
achieve the final result. 
Comparison of ligand binding sites. The initial workflow design used a single step to 
compare the three items: the binding sites of experimental structures, the binding sites 
of the homology models, and the binding sites of the proteins to which drugs were 
bound. Examining the SMAP software and associated scripts revealed that comparison 
occurred in two steps: one to compare the experimental binding sites with the drug 
binding sites, and one to compare the homology model binding sites with the drug 
binding sites. 
To clarify how the outputs of both SMAP invocations were combined, the authors 
provided the script that invoked the SMAP software. This revealed a new step for 
sorting the results. In addition, there was an additional step where the results below a 
given p-value were filtered out. 
The SMAP software has several configuration parameters. Without the author’s 
configuration files, default values of the parameters were used not knowing if the 
workflow would produce questionable results. That is, it is not clear whether without 
the same parameter settings the original method would be reproduced and similar 
results would be obtained. For these reasons, the original configuration files were 
obtained from the authors. This suggests that it would be good practice for authors 
to publish not just a description of the software used and the data used in the 
original experiment, but also the configuration files used. 
It also became clear that the data published as tables in the original article were not the 
direct input to the SMAP software, and some transformations would be required in 
order to use these data in the workflow. We recommend that when data is published 
in formats that make it more readable, the actual data that is input for software to 
run also be made available. 
Another issue concerned the constant evolution of the software tools that are used for 
the method steps. In our case, the SMAP software had evolved since the publication of 
the original paper. As with many software tools used in biology, SMAP is an active 
research effort and its functionality continues to improve. When the workflow was 
reproduced there was a new version of SMAP that had the same basic functionality, but 
produced slightly different results. Under normal research circumstances, it is not 
critical that the workflow reproduce the exact execution results, but that the conclusions 
drawn from those results still hold. An interesting result would be if the workflow was 
run again with a newer more powerful tool and there were additional findings over and 
above the original publication. The same can be said for new and more comprehensive 
sources of input data. The possibility of easily re-running and checking the method 
periodically with new versions of software tools and/or data that might lead to 
additional findings may entice researchers to keep their methods more readily 
reproducible. 
Global comparison of protein structures. Inspecting the scripts used by the authors 
revealed two steps for this subsection not mentioned in the original article. The first step 
generates a list of significant comparisons, which is used in the second step to remove 
significantly similar pairs of global structures from the FATCAT output. An expert in 
the domain would infer the need for these steps from the published article – only one 
structure from a set with similar global structures is needed to reach the appropriate 
conclusions. The article mentions the use of a threshold of 0.05, but this value did not 
appear in any parameter file. The FATCAT documentation mentions that 0.05 is a 
default value used to filter results, so this threshold did not have to be reflected in the 
workflow since it was fixed by the software – hard for a novice to know. Thus the 
workflow for this subsection could not be recreated just from the article alone, but 
required the scripts from the authors. Authors should be encouraged to publish any 
software and parameter files that were written by them and that became part of the 
method, because public domain software tools are only part of the software required to 
reproduce the method. 
An important issue regarding reproducibility came up in this subsection of the 
workflow. Although the method was reproduced with all of the necessary steps, the 
execution of the FATCAT step failed. The reason for the failure was that some of the 
PDB (protein) ids used in the input list had been superseded by newer structures in the 
PDB. Therefore, an additional component was added to check availability and replace 
any obsolete protein with its superseded version. This issue will not be unusual in 
reproducibility. Many experiments rely upon third party data sources that change 
constantly. Consequently, it is to be expected that these sources may not always be 
available and that the results that they return for the same given query may not always 
be the same. In our case, the changes in the PDB were addressed by adding a step that 
updated the older IDs with the new ones. This suggests that some published results 
that depend on third party data sources may not always be reproducible exactly, 
so it would be good practice to publish all intermediate data from the experiment 
so that the method followed can be examined when re-execution is not possible. An 
alternative is that data archives provide access to their contents for each version. 
Docking. The raw interaction network resulting from the first subsection of the method 
(comparison of ligand binding sites) was assumed to be the input for docking. It turns 
out that although the input for docking is data produced by SMAP, it is not the raw 
interaction network that it outputs. Instead, it is data that SMAP places in an 
“alignment” folder - only expert users would be aware of this. 
The original article refers to adding cofactors to relevant proteins prior to docking, 
which could be interpreted to be a step prior to docking. As it turns out, there is no 
explicit step for handling the cofactors since this is handled by manually editing the 
appropriate PDB file. Again, only expert users would be aware of this. 
Examination of the author’s scripts revealed some additional steps: calculating the clip 
files, which are used for obtaining the ideal ligands before docking. Clip files are 
mentioned in the article as containing the aligned drug molecules, so it would seem to a 
non-expert that the aligned molecules would be the output of the initial alignment steps 
of the overall method. 
A major issue with this portion of the workflow is that the docking software used for the 
original article was no longer used in the laboratory. It is proprietary software, and its 
license had expired, so alternative software (AutodockVina) with similar functionality 
has been adopted since the original article was published. Some of the ligands were not 
recognized by this software, so a transformation step had to be added to the workflow to 
make Autodock Vina work correctly. 
There are reasons why authors use proprietary software, for example, ease of use, 
support, robustness, visualization and data types supported. However, the authors could 
replicate the method before publication using open source tools, which would facilitate 
reproducibility by others. The use of open source software instead of proprietary 
software facilitates the reproduction of the software steps originally used by the 
authors, and should be the preferred mode of publication of methods and 
workflows. 
Reproducibility Maps 
We present reproducibility maps created as a summary of the reproducibility scores for 
all the major steps in the workflow. Figure 3 shows the reproducibility maps for each of 
the subsections, summarizing the reproducibility scores assigned to each step. For each 
section of the method, we show a progression of steps from left to right, noting on the 
right hand side the category of reproducer represented (MINIMAL, NOVICE, and 
AUTHOR). A step is shown in red if it was not reproducible by that category of user, 
and green if it were. 
 
Figure 3. Reproducibility maps of the three major subsections of the workflow. 
A step is shown in red if it was not reproducible by that category of user, and green if it 
were. 
doi:10.1371/journal.pone.0080278.g003 
Our observation was that a researcher with minimal knowledge of the domain would 
only be able to reproduce one of the fourteen steps in the workflow. A novice researcher 
would be able to reproduce seven of the fourteen steps: the six steps to compare ligand 
binding sites, only one of the four steps to compare the protein structures, and none of 
the steps for docking. For docking, our conclusion was that only expert researchers with 
advanced knowledge of the domain would be able to reproduce the steps. The original 
software was no longer available, and advanced expertise was required to identify 
equivalent software to replace it, and to write the software necessary to make it work as 
needed. Expert researchers would be able to reproduce the method, as the original 
article combined with the data and software published in the site would be sufficient to 
infer any missing information. A detailed rationale for the scores can be found in the 
reproducibility scores subsection of Supplement S1. 
Regarding the results, we checked that the output of the workflow included all the drugs 
exposed in the original work (plus new findings). The ranking of drugs in the results of 
the workflow is almost the same as the original, although the number of connections 
found for each drug is significantly higher in the results of the workflow. A possible 
reason is changes in the version of the software tools and updates to the external 
databases where the structures are stored. A detailed comparison can be seen in the 
original results versus results from the workflow subsection of Supplement S1. 
Productivity and Effort 
We kept detailed records in a wiki of the effort involved in reproducing the method 
throughout the project. These records are publicly available from [36]. 
We estimated the overall time to reproduce the method as 280 hours for a novice with 
minimal expertise in bioinformatics. The effort included analyzing the paper and the 
original author’s web site and additional materials (data, scripts, configuration files) to 
understand the details of the method, locating and preparing the codes, finding 
appropriate parameter settings, implementing the workflows, asking questions to the 
authors when necessary, and validating the workflows. It should be noted that the 
authors of the original experiment were available to answer questions (notably 
Kinnings, the first author). These questions were related to missing configuration 
parameters, documentation for the proper invocation of the tools, and validation of the 
outcome of the intermediate steps. Table 1 estimates the time required to reproduce the 
method and is broken down by major tasks according to our records. 
 
Table 1. Time to reproduce the method. 
doi:10.1371/journal.pone.0080278.t001 
Publishing the Reproduced Workflow 
Now that we had invested significant effort in reproducing the workflow, our goal was 
to maximize its reusability. 
First, the executed workflow was published using the Open Provenance Model [32]. 
This model is used by many workflow systems, so it increases the workflow reusability 
because it can be imported into other systems depending on the preference of the 
particular research group. We also publish the workflow provenance using the PROV 
ontology [45], a recent standard for provenance from the W3C [46]. This makes the 
published workflow independent of the workflow system used to create it. 
Second, we published an abstract workflow that complements it. The abstract workflow 
describes the steps in a manner that is independent of the software used to implement 
them. For this we used an extension of the Open Provenance Model called OPMW [47] 
that includes new terms to describe abstract steps. 
Third, we published the workflow and all of its constituents (including input and output 
data, software and scripts for the steps) as Linked Data [48], which means that each 
constituent of the workflow can be accessed by its URI through HTTP, and its 
properties are described using W3C RDF standards [49]. This means that the published 
workflow is accessible over the Web, in a way that does not require figuring out how to 
access institutional catalogs or file systems. 
With this maximally open form of publication of the workflow, the effort that we 
invested in reproducing the workflow does not have to be incurred by others. Each step 
and its inputs and outputs are explicitly and separately represented as well as linked to 
the workflow. The software for each step is available as well, as are the intermediate 
and final results. 
The effort involved in creating a workflow is negligible compared with the time to 
implement the computational method. Implementing the computational method 
typically takes months, and involves activities such as finding software packages that 
implement some of the steps, figuring out how to set up the software (e.g., setting up 
parameters) to suit the data, and writing new code to reformat the data to fit those 
packages. Once this is all done, creating the workflow can be done in a few hours, and 
can be as simple as wrapping each step so it can be invoked as a software component 
and expressing the dataflow among the components. Learning to create simple 
workflows requires only a few hours, more advanced capabilities clearly require 
additional time investment (e.g., running workflows in a cluster, depositing results in a 
catalog, or expressing a complex control flow). Similarly, publishing workflows takes 
no effort at all since the workflow system takes care of the publication. 
Technical details on how the workflow is published can be found in [50]. The OWL 
ontologies for OPM and PROV that express all the underlying RDF properties can be 
browsed from [51]. All the materials related to the workflow and its execution results 
have been published online [36]. Additionally, input and output datasets have been 
associated to DOIs and uploaded to a persistent data sharing repository [52]. 
Discussion 
Reproducibility is considered a cornerstone of the scientific method and yet rarely is 
scientific research reproducible without significant effort, if at all [5]-[7]. Authors 
submitting papers know this; as do those reading the papers and trying to reproduce the 
experiment. For computational work like that described here, where data, methods, and 
control parameters are all explicitly defined there is less of an excuse for not making the 
work reproducible. Note that making the software available or accessible through a 
webserver, while commendable, is not the same as making the work reproducible. 
Workflows, which define the scientific process as well as all the components, provide 
the tools for improved reproducibility. While workflows are commonly used for highly 
repetitive tasks, they are less used for earlier stage research. Whether this is a result of 
shortcomings in the tools or insufficient emphasis on the need to make work 
reproducible requires further consideration. This then raises the further issue of whether 
the emphasis itself is justified. Do we really care if work is exactly reproducible? This 
generally only becomes important if some variation of the original work cannot be 
reproduced at all, then the original work is fully scrutinized. This speaks to a need for 
better quantification of what is really needed to improve productivity in science. When, 
as is the case here, the experiment is conducted completely in silico, the opportunity to 
accurately capture what has transpired becomes a relatively straightforward task (i.e., 
there is a relatively favorable cost:benefit ratio) and raises the question as to whether the 
community of computational biologists should do better. What does doing better imply? 
We believe it is rare that work is purposely made irreproducible; rather the system of 
peer review speaks to reproducibility but is cursory in demanding it. The scientific 
reward is in publishing another paper, not making your current paper more reproducible. 
Tools help, but changes in policy are also needed. It will be a brave publisher indeed 
that demands that workflows be deposited with the paper. Publishing after all is a 
business and if one publisher demands workflows, authors are more likely to publish 
elsewhere than go to the trouble. Journals are beginning to provide guidelines for 
reproducibility and minimum requirements for method descriptions [53]–[54]. There is 
already a concept of “data publication,” where datasets are described and receive a 
unique identifier and a publication. Similarly, there should be a concept of “workflow 
publication.” There is no explicit credit for publishing software packages, and many 
people do it. The credit comes indirectly from acknowledgement by the community that 
the software is useful. Perhaps publishing end-to-end methods as workflows would 
bring similar reputation. For this to work, authors must be recognized and credited by 
other researchers reusing their workflow. We posit that the authors of the original 
method need not be the ones publishing the workflow. Third parties interested in 
reproducing the method could publish the workflow once reproduced, and get credit not 
for the method but for the workflow as a reusable software instrument. In one sense this 
is no different than taking other scientists data and developing a database that extends 
the use of these data to a wider community. It is a value-added service worthy of 
attention through publication. 
Federal mandates similar to those emerging around shared data could also be put in 
place for reproducibility too. In the end, funding for science ultimately comes from 
taxes from the public, and we need to be responsible in making science as efficient and 
productive as possible. Many government agencies already require data to be published 
and shared with other researchers. Workflows should follow the same path. The recent 
emphasis on open availability of research products resulting from public funds [55]–
[56] will eventually include the publication of software and the methods (workflows). 
This will likely be sometime coming as the easier issue of meaningful data provision is 
not fully understood and solved yet. Notwithstanding, if this remains a difficult issue on 
a global scale we can make progress in our own laboratories. 
A new researcher coming to almost any laboratory and picking up tools used by 
previous laboratory members can likely testify to what is described in this paper. If we 
are to accelerate scientific discovery we must surely do better both within a laboratory 
and beyond. This is particularly important in an era of interdisciplinary science where 
we often wish to apply methods that we are not experts in. Some would argue that 
irreproducibility in the laboratory is part of the learning process; we would argue yes, 
but with so much to learn that is more relevant to discovery we should do better now 
that we have tools to assist us. 
Or should we? Reproducibility aside, is there indeed a favorable cost:benefit ratio in 
using workflows with respect to productivity? There is a dearth of literature that 
addresses this question. Rather the value of the workflow is assumed and different 
workflow systems on different computer architectures are analyzed for their relative 
performance. At best the question can be addressed by work habits. We must be careful 
as such work habits could be mandated, in a large company say, rather than by choice, 
which would be the case in an independent research laboratory. Creating workflows 
results in overhead for exploratory research, where many paths are discarded. However, 
once created a workflow can be reused many times. This makes them ideal for repetitive 
procedures such as might be found in aspects of the pharmaceutical industry. 
Pharmaceutical companies use workflows for computational experiments [57]. This 
means there must be a business case for workflows in terms of saving time and effort 
and/or facilitating quality control. Taking an independent computational biology 
laboratory, as is the case for this study, it is fair to say that workflows are making 
inroads into daily work habits. These inroads are still localized to specific subareas of 
study – Galaxy [58] for high-throughput genomic sequence analysis; KNIME [59] for 
high-throughput drug screening, and so on, but with that nucleation and with new 
applications being added by an open source-minded community, adoption is increasing. 
Adoption would assume a favorable cost:benefit ratio in that use of a workflow system 
provides increased productivity over not using such a system. This is a cost measured in 
time rather than money since most academic laboratories in computational biology 
would use free open source workflow systems. Finally, when articles cannot be easily 
reproduced the authors are often contacted to clarify or describe additional details. This 
requires effort that might as well have been invested in writing the article more 
precisely in the first place. 
Workflows can also be seen as an important tool to make the research in a lab more 
rigorous. Analyses must be captured so they can be inspected by others and errors 
detected as easily as possible. For example, writing code to transform data makes the 
transformation inspectable, while using a spreadsheet to do the task makes it much 
harder to verify that it was done correctly. Ensuring consistency and reproducibility 
requires more effort without workflows. In our own laboratory we find that the 
workflow can act as a reference such that new users can more quickly familiarize 
themselves with the various applications than would be the case without the benefit of 
the workflow organization, but then choose to go on and run applications outside of the 
workflow system. As the workflow systems themselves continue to be easier to use and 
more intuitive we anticipate that more work will be done within the workflow system 
itself, presumably improving productivity. 
For the practitioner, what are the pluses and minuses of workflow use today? An 
obvious minus is the time required to establish the workflow itself. In some sense this is 
analogous to documenting a procedure to run a set of software programs. But in most 
cases once codes are prepared for publication little additional effort is required to 
include them in a workflow. The advantage of a workflow is that capturing the steps 
themselves defines the procedure and it can be re-run, in principle, without any further 
effort. We say “in principle” since as this work has shown workflows decay – the tools 
available change, the licenses to those tools change, remote data accessibility changes 
etc. Virtual machines offer the promise of capturing the complete executable 
environment for future use, however they introduce other issues [26]. For example, 
virtual machines often act as black boxes that allow repeating the experiment verbatim, 
but do not allow for any changes to the computational execution pipeline, limiting its 
reproducibility. Furthermore, virtual machines cannot store external dynamic databases 
accessed at runtime (like the PDB in our work) due to their size. These databases are 
commonly used for experiments in computational biology. 
All taken together, it may be that we are at this tipping point of broad workflow 
adoption and it will be interesting to review workflow use by the computational biology 
community two or more years from now. 
Conclusions 
We conclude by summarizing the main observations resulting from our work, leading to 
desiderata for reproducibility shown in Table 2, and a set of guidelines for authors 
shown in Table 3. We have restrained from making too many absolute conclusions from 
a single instance of applying a workflow to a scientific method. It would be interesting 
to carry out similar studies in other domains and compare findings. 
 
Table 2. Observations and desiderata for reproducibility. 
doi:10.1371/journal.pone.0080278.t002 
 
Table 3. Reproducibility Guidelines for Authors. 
doi:10.1371/journal.pone.0080278.t003 
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